Skip to main content
. 2023 Feb 2;13(2):425. doi: 10.3390/life13020425

Table 1.

Personal Experience of Partial Adrenalectomies for the Treatment of MEN2-PHEOs.

Age Gender Year MEN2
Syndrome
Laterality Procedure Operative Time (Minutes) POS (Days) Follow-Up
28 Female 2017 2B (no
further informations available)
Right
Metachronous
(Left TLA TA, 2010)
Right PA
(TLA)
70 7.
No post-operative complications
60 months: Right
recurrence that
required right CA.
Hydrocortison 30 mg/day
36 Female 2020 2A,
C634R
Bilateral
Synchronous
Left TA +
Right PA
(PRA)
118 4.
No post-operative complications
23 months.
No recurrence. Hydrocortison 10 mg/day
36 Male 2021 2A,
C634R
Left
Metachronous (Right TLA TA, 2014)
Left PA
(TLA)
53 3.
No post-operative complications
20 months.
No recurrence.
Hydrocortison 20 mg/day
26 Male 2021 2A,
C634R
Right Right PA
(TLA)
77 2.
No post-operative complications
11 months.
No recurrence.
No SI
51 Female 2022 2A,
C618R
Left
Metachronous (Right TLA TA, 2011)
Left PA
(TLA)
67 3.
No post-operative complications
3 months.
No recurrence.
Hydrocortison 20 mg/day
39 Female 2022 2A,
C634R
Bilateral
Synchronous
Right TA +
Left PA
(PRA)
75 5.
No post-operative complications
1 month.
No recurrence.
Hydrocortison 30 mg/day

TLA: Transabdominal Lateral Adrenalectomy. PRA: Posterior Retroperitoneoscopic Adrenalectomy. POS. Postoperative Hospital Stay. CA: Completion of Adrenalectomy.